ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

Harvard’s Harvey Fineberg Is Elected IOM President.

November 16, 2001

Clinical Trials Approved By NCI

September 26, 2003

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Herberman: Progress Made To Stabilize NSABP

September 9, 1994